Small Animal Clinical Nutrition

The most comprehensive and practical small animal nutrition resource available.

Chapter 28: Disorders of Lipid Metabolism References


Allerman AR. The effects of hemolysis and lipemia on serum biochemical constituents. Veterinary Medicine 1990; 85: 1272-1284.

Anderson JW, Allgood LD, Lawerence A, et al. Cholesterol-lowering effects of psyllium intake adjunctive to diet therapy in men and women with hypercholesterolemia: Meta-analysis of 8 controlled trials. American Journal of Clinical Nutrition 2000; 71: 472-479.

Armstrong PJ, Ford RB. Hyperlipidemia. In: Kirk RW, ed. Current Veterinary Therapy X. Philadelphia, PA: WB Saunders Co, 1989; 1046-1050.

Barrie J, Watson TDG, Stear MJ, et al. Plasma cholesterol and lipoprotein concentration in the dog: The effect of age, breed, gender and endocrine disease. Journal of Small Animal Practice 1993; 34: 507-712.

Behall KM, Scholfield DJ, Jallfrisch J. Diets containing barley significantly reduce lipids in mildly hypercholesterolemic men and women. American Journal of Clinical Nutrition 2004; 80: 1185-1193.

Bernard DB. Metabolic abnormalities in nephrotic syndrome: Pathophysiology and complications. In: Brenner BM, Stein JH, eds. Contemporary Issues in Nephrology, vol. 9: Nephrotic Syndrome. New York, NY: Churchill Livingstone, 1982; 87-120.

Brown MS, Goldstein JL. The hyperlipoproteinemias and other disorders of lipid metabolism. In: Braunwald E, Isselbacher KJ, Petersdorf RG, et al, eds. Harrison’s Principles of Internal Medicine, 11th ed. New York, NY: McGraw-Hill, 1987; 1650-1661.

Chapman MJ. Animal lipoproteins: Chemistry, structure, and comparative aspects. Journal of Lipid Research 1980; 21: 789-853.

Crispin SM. Ocular manifestations of hyperlipoprotaeinemia. Journal of Small Animal Practice 1993; 34: 500-506.

DeBowes LJ. Lipid metabolism and hyperlipoproteinemia in dogs. Compendium on Continuing Education for the Practicing Veterinarian 1987; 9: 727-731.

Diez M, Grauwels M, Jeusette IC, et al. Short-chain fructo-oligosaccharides in hyperlipidaemic dogs. In: Proceedings. ICC/AOAC International Conference 2000, May 13-18; 138.

Eckel RH. Lipoprotein lipase. New England Journal of Medicine 1989; 16: 1060-1068.

Ford RB. Canine hyperlipidemia. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine, 4th ed. Philadelphia, PA: WB Saunders Co, 1995; 1414-1419.

Ford RB. Clinical management of lipemic patients. Compendium on Continuing Education for the Practicing Veterinarian 1996; 18: 1053-1065.

Ford RB. Idiopathic hyperchylomicronemia in miniature schnauzers. Journal of Small Animal Practice 1993; 34: 488-492.

Gotto AM. Lipoprotein metabolism and the etiology of hyperlipidemia. An update: Pharmacologic approaches to the hyperlipidemias. Hospital Practice 1988 (Suppl. 1); 23: 4-13.

Hunninghake DB, Miller VT, LaRosa JC, et al. Long-term treatment of hypercholesterolemia with dietary fiber. American Journal of Medicine 1994; 97: 504-508.

Jeusette IC, Grauwels M, Cuvelier C, et al. Hypercholesterolemia in a family of rough collie dogs. Journal of Small Animal Practice 2004; 45: 319-324.

Jeusette IC, Lhoest ET, Istasse LP, et al. Influence of obesity on plasma lipid and lipoprotein concentrations in dogs. American Journal of Veterinary Research 2005; 66: 81-86.

Jones BR, Wallace A, Harding DRK, et al. Occurrence of idiopathic, familial hyperchylomicronaemia in a cat. Veterinary Record 1983; 112: 543-547.

Jones BR, Watson TDG. In: Proceedings. Specialist Session on Lipid Disorders. British Small Animal Veterinary Association Annual Congress, Birmingham, UK, 1995.

Jones BR. Feline hyperlipidemia. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine, 4th ed. Philadelphia, PA: WB Saunders Co, 1995; 1410-1414.

Jones BR. Inherited hyperchylomicronaemia in the cat. Journal of Small Animal Practice 1993; 34: 493-499.

Levy RI. Currently available lipid-lowering agents. An update: Pharmacologic approaches to the hyperlipidemias. Hospital Practice 1988 (Suppl. 1); 23: 14-21.

Linton LL, Moore CP, Collier LL. Bilateral lipid keratopathy in a boxer dog: Cholesterol analyses and dietary management. Progress in Veterinary and Comparative Ophthalmology 1994; 3: 9-14.

Logas D, Beale KM, Bauer JE. Potential clinical benefits of dietary supplementation with marine-life oil. Journal of the American Veterinary Medical Association 1991; 199: 1631-1636.

Mahley RW, Weisgraber KH, Innerarity T. Canine lipoproteins and atherosclerosis II. Characterization of the plasma lipoprotein associated with atherogenic and nonatherogenic hyperlipidemia. Circulation Research 1974; 35: 722-733.

Mahley RW, Weisgraber KH. Canine lipoproteins and atherosclerosis I. Isolation and characterization of plasma lipoproteins from control dogs. Circulation Research 1974; 35: 713-721.

Maki KC, Shinnick F, Seeley MA, et al. Food products containing free tall oil-based phytosterols and oat beta-glucan lower serum total and LDL cholesterol in hypercholesterolemic adults. Journal of Nutrition 2003; 133: 808-813.

Marlett JA. Sites and mechanisms for the hypocholesterolemic actions of soluble dietary fiber sources. Advances in Experimental Medicine and Biology 1997; 103: 109-121.

Naito HK. The clinical significance of apolipoprotein measurements. Journal of Clinical Immunoassay 1986; 9: 11-20.

Rogers WA, Donovan EF, Kociba GJ. Idiopathic hyperlipoproteinemia in dogs. Journal of the American Veterinary Medical Association 1975; 166: 1087-1099.

Rogers WA, Donovan EF, Kociba GJ. Lipids and lipoproteins in normal dogs and dogs with secondary hyperlipoproteinemia. Journal of the American Veterinary Medical Association 1975a; 166: 1092-1100.

Rogers WA. Lipemia in the dog. Veterinary Clinics of North America: Small Animal Practice 1977; 7: 637-640.

Sanfey H, Cameron JL. Pancreatitis and hyperlipemia. In: Berk JE, ed. Gastroenterology, 4th ed. Philadelphia, PA: WB Saunders Co, 1985; 4055-4071.

Sato K, Agoh H, Kaneshige T, et al. Hypercholesterolemia in Shetland sheepdogs. Journal of Veterinary Medical Science 2000; 62(12): 1297-1301.

Schaefer EJ, Levy RI. Pathogenesis and management of lipoprotein disorders. New England Journal of Medicine 1985; 312: 1300-1310.

Schaefer EJ. When and how to treat the dyslipidemias. Hospital Practice 1988; 23: 69-84.

Swain JF, Rouse IL, Curley CB, et al. Comparison of the effect of oat bran and low-fiber wheat on serum lipoprotein levels and blood pressure. New England Journal of Medicine 1990; 322: 147-152.

Watson P, Simpson KW, Bedford PG. Hypercholesterolaemia in briards in the United Kingdom. Research in Veterinary Science 1993; 54: 80-85.

Watson TDG, Barrie J. Lipoprotein metabolism and hyperlipidaemia in the dog and cat: A review. Journal of Small Animal Practice 1993; 34: 479-487.

Watson TDG. Diagnosis and management of hyperlipidemia in dogs and cats. In: Proceedings. Fourteenth Annual Veterinary Medical Forum, American College of Veterinary Internal Medicine, San Antonio, TX, 1996: 65-66.

Weinberg RB. Lipoprotein metabolism: Hormonal regulation. Hospital Practice 1987; 22: 223-243.

Whitney MS, Boon GD, Rebar AH, et al. Effects of acute pancreatitis on circulating lipids in dogs. American Journal of Veterinary Research 1987; 48: 1492-1497.

Whitney MS. Evaluation of hyperlipidemias in dogs and cats. Seminars in Veterinary Medicine and Surgery: Small Animal 1992; 7: 292-300.

Williams DA. Exocrine pancreatic disease. In: Ettinger SJ, Feldman EC, eds. Textbook of Veterinary Internal Medicine, 4th ed. Philadelphia, PA: WB Saunders Co, 1995; 1372-1392.

Zerbe CA. Canine hyperlipidemias. In: Kirk RW, ed. Current Veterinary Therapy IX. Philadelphia, PA: WB Saunders Co, 1986; 1045-1053.



Box 28-2 Bibliography

Briand F, Bailhache E, Nyugen P, et al. Effects of insulin resistance on reverse cholesterol transport, apo a-i kinetics and selective uptake of cholesteryl esters in dogs. In: Proceedings. American College of Veterinary Internal Medicine, Baltimore, MD, 2005.

Davis HR, Pula KK, Alton KB, et al. The synergistic hypocholesterolemic activity of the potent cholesterol absorption inhibitor, ezetimibe, in combination with 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in dogs. Metabolism 2001; 50: 1234-1241.

Harris WS. Pharmacologic management of hyperlipidemias. In: Proceedings. Fourteenth Annual Veterinary Medical Forum, American College of Veterinary Internal Medicine, San Antonio, TX, 1996: 63-64.

Steiner M, Khan AH, Holbert D, et al. A double-blind crossover study in moderately hypercholesterolemic men that compared the effect of aged garlic extract and placebo administration on blood lipids. American Journal of Clinical Nutrition 1996; 64: 866-870.

Watson TDG. Diagnosis and management of hyperlipidemia in dogs and cats. In: Proceedings. Fourteenth Annual Veterinary Medical Forum, American College of Veterinary Internal Medicine, San Antonio, TX, 1996: 65-66.






Copyright Ⓒ 2019 Mark Morris Institute